Masayuki Ii

2.4k total citations
17 papers, 2.0k citations indexed

About

Masayuki Ii is a scholar working on Immunology, Cancer Research and Molecular Biology. According to data from OpenAlex, Masayuki Ii has authored 17 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Masayuki Ii's work include Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Masayuki Ii is often cited by papers focused on Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Masayuki Ii collaborates with scholars based in Japan, United States and Belgium. Masayuki Ii's co-authors include Naoko Matsunaga, Tomoyuki Kitazaki, Yuji Iizawa, Tatsumi Matsumoto, Noboru Tsuchimori, Mie Sunamoto, Hiroyuki Kimura, Tomohiro Kawamoto, Katsunori Takashima and Koji Ohnishi and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Masayuki Ii

17 papers receiving 2.0k citations

Peers

Masayuki Ii
Qianbin He United States
Daiva Svetkauskaite United States
Riikka Kokkola Sweden
Emilie Vénéreau Italy
Ricardo Sánchez‐Rodríguez Italy
Xia Zhao China
Francesco De Marchis Italy
Justine Newson United Kingdom
Pascal Knuefermann Germany
Qianbin He United States
Masayuki Ii
Citations per year, relative to Masayuki Ii Masayuki Ii (= 1×) peers Qianbin He

Countries citing papers authored by Masayuki Ii

Since Specialization
Citations

This map shows the geographic impact of Masayuki Ii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Ii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Ii more than expected).

Fields of papers citing papers by Masayuki Ii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Ii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Ii. The network helps show where Masayuki Ii may publish in the future.

Co-authorship network of co-authors of Masayuki Ii

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Ii. A scholar is included among the top collaborators of Masayuki Ii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Ii. Masayuki Ii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rice, Todd W., Arthur P. Wheeler, Gordon R. Bernard, et al.. (2010). A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*. Critical Care Medicine. 38(8). 1685–1694. 392 indexed citations
2.
3.
Matsunaga, Naoko, Noboru Tsuchimori, Tatsumi Matsumoto, & Masayuki Ii. (2010). TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules. Molecular Pharmacology. 79(1). 34–41. 480 indexed citations
4.
Seki, Hiroyuki, Sadatomo Tasaka, Koichi Fukunaga, et al.. (2010). Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury. Inflammation Research. 59(10). 837–845. 39 indexed citations
5.
Yamada, Masami, Takashi Ichikawa, Masayuki Ii, et al.. (2008). Novel cyclohexene derivatives as anti-sepsis agents: Synthetic studies and inhibition of NO and cytokine production. Bioorganic & Medicinal Chemistry. 16(7). 3941–3958. 32 indexed citations
6.
Kawamoto, Tomohiro, Masayuki Ii, Tomoyuki Kitazaki, Yuji Iizawa, & Hiroyuki Kimura. (2008). TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. European Journal of Pharmacology. 584(1). 40–48. 267 indexed citations
7.
Sunamoto, Mie, et al.. (2007). Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. European Journal of Pharmacology. 571(2-3). 231–239. 154 indexed citations
8.
Kravchenko, Vladimir V., Shuang Huang, Masayuki Ii, et al.. (2006). NF-κB-Inducing Kinase Regulates Selected Gene Expression in the Nod2 Signaling Pathway. Infection and Immunity. 74(4). 2121–2127. 42 indexed citations
9.
10.
11.
Ii, Masayuki, Mie Sunamoto, Naoko Matsunaga, et al.. (2004). TAK-242 SUPPRESSES TOLL-LIKE RECEPTOR 4-MEDIATED CYTOKINE PRODUCTION AND PROTECTS MICE FROM ESCHERICHIA COLI-INDUCED LETHALITY. Critical Care Medicine. 32(Supplement). A15–A15. 3 indexed citations
12.
Ii, Masayuki, et al.. (2004). A NOVEL CYTOKINE PRODUCTION INHIBITOR, TAK-242, PREVENTS LPS-INDUCED CYTOKINE PRODUCTION AND LETHALITY IN MICE. Critical Care Medicine. 32(Supplement). A129–A129. 1 indexed citations
13.
Zanotti-Cavazzoni, S.L., Roy D. Goldfarb, R. Phillip Dellinger, et al.. (2004). A CYTOKINE PRODUCTION INHIBITOR (TAK-242) IMPROVES CARDIOVASCULAR PERFORMANCE, INHIBITS CYTOKINE RELEASE AND INCREASES SURVIVAL IN A PORCINE MODEL OF GRAM-NEGATIVE SEPSIS. Critical Care Medicine. 32(Supplement). A15–A15. 6 indexed citations
14.
Ii, Masayuki, K Sayama, Mikiko Tohyama, & Kunihiko Hashimoto. (2002). A case of cold-dependent exercise-induced anaphylaxis. British Journal of Dermatology. 147(2). 368–370. 15 indexed citations
15.
Ii, Masayuki, Mie Sunamoto, Koji Ohnishi, & Yuzo Ichimori. (1996). β-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Research. 720(1-2). 93–100. 148 indexed citations
16.
Kawasaki, Toshisuke, Masayuki Ii, & Ikuo Yamashina. (1989). [26] Galactose/N-acetylgalactosamine-binding protein and mannose/l-fucose/N-acetylglucosamine-binding proteins from rat peritoneal macrophages. Methods in enzymology on CD-ROM/Methods in enzymology. 179. 322–327. 1 indexed citations
17.
Ii, Masayuki, Toshisuke Kawasaki, & Ikuo Yamashina. (1988). Structural similarity between the macrophage lectin specific for galactose/N-acetylgalactosamine and the hepatic asialoglycoprotein binding protein. Biochemical and Biophysical Research Communications. 155(2). 720–725. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qianbin He Breakdown of academic impact, for papers by Daiva Svetkauskaite Breakdown of academic impact, for papers by Riikka Kokkola Breakdown of academic impact, for papers by Emilie Vénéreau Breakdown of academic impact, for papers by Ricardo Sánchez‐Rodríguez Breakdown of academic impact, for papers by Xia Zhao Breakdown of academic impact, for papers by Francesco De Marchis Breakdown of academic impact, for papers by Justine Newson Breakdown of academic impact, for papers by Pascal Knuefermann
Rankless by CCL
2026